{"id":"46b90fd5-9421-4d15-a20e-022fe7b89fc4","kind":"news","code":"46b90fd5-9421-4d15-a20e-022fe7b89fc4","name":"Beacon Biosignals raises USD 86 million in Series B financing","nameBasis":"translated-title","summary":"","description":"","country":null,"category":null,"originalName":"Beacon Biosignals完成8600万美元B轮融资","eventDate":"2025-11-14T00:00:00.000Z","website":null,"sourceUpdatedAt":"2026-10-10T18:51:48.824Z","englishUpdatedAt":"2026-10-15T17:19:59.451Z","reviewedAt":"2026-10-15T17:19:59.451Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"1c9a8d7af2a0fd0178f098d60b67fb65728cdcb93f7a0735655a35de7b306f7a","companyId":"e3e6741f-8457-4043-8a49-2ea9f765c695","foundedYear":null,"logoUrl":null,"originalText":"","sources":[],"related":[{"id":"e3e6741f-8457-4043-8a49-2ea9f765c695","kind":"companies","code":"UB-C2791","name":"Beacon Biosignals","nameBasis":"source-english","summary":"","description":"","country":"United States","category":null,"originalName":"Beacon Biosignals","eventDate":null,"website":"https://beacon.bio/","sourceUpdatedAt":"2026-10-03T00:00:00.000Z","englishUpdatedAt":"2026-10-20T18:26:42.461Z","reviewedAt":"2026-10-20T18:26:42.461Z","snapshotAt":"2026-10-20T18:05:01.520Z","sourceHash":"c457cef333faa2e6837d36b77430c105ce63b8c635248c5c0d49c40c93f0c470","companyId":null,"foundedYear":2019,"logoUrl":null,"path":"/companies/beacon-biosignals"},{"id":"b2012397-bdea-4ede-9475-be3362b62c96","kind":"institutions","code":"UB-I061","name":"General Catalyst","nameBasis":"original-brand","summary":"A prominent US venture capital firm focused on early- and growth-stage technology and life sciences investments.","description":"A prominent US venture capital firm focused on early- and growth-stage technology and life sciences investments.","country":"United States","category":null,"originalName":"General Catalyst","eventDate":null,"website":"https://generalcatalyst.com/","sourceUpdatedAt":"2026-10-20T07:00:15.404Z","englishUpdatedAt":"2026-10-20T18:27:03.248Z","reviewedAt":"2026-10-20T18:27:03.248Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"851a2e8828f240ae85d6f75ec01b2cce5155c9943842c6cb806148d2e4f3f908","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/general-catalyst"},{"id":"f8c88419-8f6c-4a71-85d4-e2adf1902d93","kind":"institutions","code":"UB-I126","name":"Google Ventures","nameBasis":"original-brand","summary":"Also known as GV, Alphabet's venture capital firm focused on early- and growth-stage technology investments.","description":"Also known as GV, Alphabet's venture capital firm focused on early- and growth-stage technology investments.","country":"United States","category":null,"originalName":"Google Ventures","eventDate":null,"website":"https://www.gv.com/","sourceUpdatedAt":"2026-10-20T07:00:15.040Z","englishUpdatedAt":"2026-10-20T18:27:14.270Z","reviewedAt":"2026-10-20T18:27:14.270Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"9ca4d862756b90d218002b471419a798e5f040441b0ec387ad4481bd2a8f75c3","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/google-ventures"},{"id":"b7ec6fab-4be0-41b6-96c9-9ceb75fd50b7","kind":"institutions","code":"UB-I2076","name":"Logos Capital","nameBasis":"original-brand","summary":"A South Korean early-stage venture capital firm focused on technology and consumer businesses.","description":"A South Korean early-stage venture capital firm focused on technology and consumer businesses.","country":null,"category":null,"originalName":"Logos Capital","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:04:21.060Z","englishUpdatedAt":"2026-10-15T20:40:58.196Z","reviewedAt":"2026-10-15T20:40:58.196Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"a9a0ed63ab290a2e3701938597d81337fc2cc3ae0dc591169e160b435a279ba6","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/logos-capital"},{"id":"34608060-7008-4c07-8e61-ba603936739e","kind":"institutions","code":"UB-I2077","name":"Takeda Pharmaceutical Co","nameBasis":"original-brand","summary":"Takeda Pharmaceutical, a large global pharmaceutical company making strategic life sciences investments through divisions including Takeda Ventures.","description":"Takeda Pharmaceutical, a large global pharmaceutical company making strategic life sciences investments through divisions including Takeda Ventures.","country":"Japan","category":null,"originalName":"Takeda Pharmaceutical Co","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-18T23:00:16.438Z","englishUpdatedAt":"2026-10-20T18:26:49.760Z","reviewedAt":"2026-10-20T18:26:49.760Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"8c713d4371fb4814bbb8b3314618bd45424f337c6a1362a74901f4fd83bd5e30","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/takeda-pharmaceutical-co"}],"path":"/news/46b90fd5-9421-4d15-a20e-022fe7b89fc4","structured":{"city":null,"country":null,"location":null,"role":null,"category":null,"company":{"name":"Beacon Biosignals","path":"/companies/beacon-biosignals"}},"canonical":"https://uniquebase.ai/news/46b90fd5-9421-4d15-a20e-022fe7b89fc4"}